Biochemistry, Genetics and Molecular Biology journals by time to acceptance (2025)
630 journals with 2025 figures · median days from submission to acceptance, measured from PubMed dates · data as of Sep 15, 2026
Sorted by median days from submission to acceptance in 2025. Faster is not better — this is a planning aid, not a ranking of quality. Click a column to re-sort.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Anti-Cancer Drugs | 0 (0–1) | 53 | 63 | — | — | 1.34 |
| Doklady Biochemistry and Biophysics | 17 (13–26) | 90 | 94 | — | — | 0.0 |
| Journal of Craniofacial Surgery | 24 (12–50) | 1,298 | 32 | — | — | 0.0 |
| Genes | 29 (22–38) | 1,505 | 3 | ≈$3,137 | Open access | 0.21 |
| Marine Drugs | 29 (23–38) | 477 | 2 | ≈$3,544 | Open access (DOAJ) | 0.0 |
| Current Issues in Molecular Biology | 34 (26–43) | 1,070 | 3 | ≈$2,689 | Open access (DOAJ) | 0.33 |
| Antibiotics | 36 (27–48) | 1,295 | 3 | ≈$3,544 | Open access (DOAJ) | 0.53 |
| Metabolites | 36 (28–48) | 817 | 4 | ≈$3,300 | Open access (DOAJ) | 0.0 |
| Microorganisms | 37 (28–49) | 2,856 | 3 | ≈$3,300 | Open access (DOAJ) | 0.0 |
| Life | 37 (28–50) | 1,920 | 3 | ≈$3,178 | Open access (DOAJ) | 0.11 |
| Biology | 37 (29–49) | 1,833 | 3 | ≈$3,300 | Open access (DOAJ) | 0.8 |
| Antioxidants | 37 (29–49) | 1,495 | 3 | ≈$3,544 | Open access (DOAJ) | 0.0 |
| Toxins | 37 (30–48) | 591 | 3 | ≈$3,300 | Open access (DOAJ) | 0.0 |
| The Plant Cell | 37 (9–99) | 285 | — | ≈$4,934 | Hybrid | 0.0 |
| International Journal of Molecular Sciences | 38 (29–50) | 11,991 | 3 | ≈$3,499 | Open access | 0.14 |
| Cancers | 38 (29–49) | 3,955 | 3 | ≈$3,499 | Open access | 0.23 |
| Cells | 39 (29–53) | 2,035 | 3 | ≈$3,300 | Open access (DOAJ) | 0.07 |
| Cancer Genomics & Proteomics | 39 (30–52) | 72 | — | — | Open access | 0.0 |
| The Journal of Liquid Biopsy | 39 (29–50) | 50 | 3 | $2,080 | Open access (DOAJ) | — |
| Biomedicines | 40 (30–52) | 2,992 | 3 | ≈$3,178 | Open access (DOAJ) | 0.35 |
| Biomolecules | 41 (31–54) | 1,761 | 3 | ≈$3,300 | Open access (DOAJ) | 0.11 |
| Redox Biology | 41 (25–67) | 483 | 2 | $4,700 | Open access (DOAJ) | 1.51 |
| Antibodies | 41 (33–59) | 107 | 5 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| BioTech | 45 (35–57) | 100 | 3 | ≈$1,956 | Open access (DOAJ) | 0.0 |
| Trends in Pharmacological Sciences | 50 (27–78) | 120 | 25 | ≈$7,030 | Hybrid | 0.0 |
| Methods and Protocols | 51 (42–65) | 157 | 5 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| Epigenomes | 52 (38–69) | 52 | 3 | ≈$1,833 | Open access (DOAJ) | — |
| Clinica Chimica Acta | 53 (32–103) | 534 | 2 | ≈$3,550 | Hybrid | 0.0 |
| Bioscience Biotechnology and Biochemistry | 53 (37–77) | 207 | — | ≈$3,272 | — | 0.89 |
| Trends in Microbiology | 54 (25–90) | 166 | 26 | ≈$7,030 | Hybrid | 0.0 |
| The Journal of Microbiology | 54 (36–81) | 96 | 60 | ≈$3,690 | — | 0.0 |
| Trends in cancer | 55 (22–87) | 121 | 23 | ≈$7,030 | Hybrid | 0.0 |
| International Journal of Neonatal Screening | 55 (40–77) | 102 | 5 | ≈$1,956 | Open access (DOAJ) | 0.0 |
| Plant Cell Reports | 56 (39–87) | 275 | 16 | ≈$4,590 | — | 0.0 |
| Current Opinion in Biotechnology | 56 (28–92) | 114 | 22 | ≈$4,530 | Hybrid | 0.0 |
| Journal of Microbiology and Biotechnology | 57 (36–82) | 298 | 39 | — | — | 0.0 |
| ACS Medicinal Chemistry Letters | 57 (40–84) | 264 | 6 | ≈$4,500 | Hybrid | 0.0 |
| Biomolecules and Biomedicine | 57 (42–87) | 200 | 17 | ≈$1,379 | Open access (DOAJ) | 0.0 |
| Biogerontology | 58 (39–104) | 194 | 12 | ≈$4,790 | Hybrid | 0.0 |
| Biochemical and Biophysical Research Communications | 59 (8–90) | 1,484 | 1 | ≈$3,110 | Hybrid | 0.15 |
| Trends in Genetics | 59 (38–83) | 102 | 27 | ≈$7,030 | Hybrid | 0.0 |
| Investigational New Drugs | 59 (39–84) | 85 | 17 | ≈$4,690 | — | 0.0 |
| Chemical & Biomedical Imaging | 60 (49–79) | 157 | 10 | $3,500 | Open access (DOAJ) | 0.0 |
| European Journal of Medicinal Chemistry | 61 (46–80) | 1,076 | 3 | ≈$4,650 | Hybrid | 0.0 |
| Bioorganic & Medicinal Chemistry | 61 (47–78) | 339 | 2 | ≈$3,960 | — | 0.0 |
| Cytoskeleton | 61 (8–104) | 100 | 12 | ≈$3,920 | — | 0.0 |
| Stem Cell Reviews and Reports | 61 (43–103) | 80 | 17 | ≈$4,390 | — | 0.0 |
| Proteomes | 61 (46–87) | 68 | 6 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| Frontiers in Molecular Biosciences | 62 (41–94) | 478 | 20 | ≈$3,850 | Open access (DOAJ) | 2.08 |
| Archives of Microbiology | 62 (44–88) | 476 | 19 | ≈$4,090 | Hybrid | 0.82 |
| Clinical Genetics | 62 (42–86) | 214 | 11 | ≈$4,980 | — | 0.0 |
| Biology Open | 62 (22–127) | 152 | 34 | $2,500 | Open access (DOAJ) | 0.0 |
| Non-Coding RNA | 62 (49–81) | 77 | 4 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| The Journal of Biochemistry | 63 (34–94) | 79 | — | ≈$3,276 | — | 0.0 |
| iMeta | 63 (43–97) | 66 | 20 | $4,960 | Open access (DOAJ) | 0.0 |
| BIO-PROTOCOL | 64 (53–81) | 375 | 36 | $1,200 | Open access (DOAJ) | 0.52 |
| Protein Expression and Purification | 64 (48–80) | 136 | 1 | ≈$3,680 | — | 0.0 |
| NeuroMolecular Medicine | 64 (46–81) | 74 | 17 | ≈$4,990 | — | 0.0 |
| Free Radical Biology and Medicine | 65 (47–98) | 635 | 1 | ≈$4,240 | Hybrid | 0.0 |
| Forensic Science International Synergy | 65 (45–105) | 53 | 9 | $2,710 | Open access (DOAJ) | 0.0 |
| Journal of Peptide Science | 66 (42–104) | 73 | — | ≈$4,030 | — | 0.0 |
| Hereditas | 67 (49–98) | 251 | 17 | $2,690 | Open access (DOAJ) | 2.33 |
| Genes to Cells | 67 (38–124) | 75 | — | ≈$3,800 | — | 0.0 |
| Frontiers in Microbiology | 68 (48–98) | 3,157 | 21 | ≈$3,850 | Open access (DOAJ) | 0.26 |
| Carbohydrate Research | 68 (51–97) | 308 | 1 | ≈$3,800 | Hybrid | 0.0 |
| Journal of Molecular Neuroscience | 68 (47–102) | 159 | 17 | ≈$4,990 | — | 1.5 |
| Biophysical Reviews | 68 (46–91) | 113 | 16 | ≈$3,990 | — | 0.0 |
| Function | 68 (38–97) | 51 | — | $3,900 | Open access (DOAJ) | 0.0 |
| Frontiers in Cell and Developmental Biology | 69 (47–99) | 1,074 | 18 | ≈$3,850 | Open access (DOAJ) | 2.23 |
| Diagnostic Microbiology and Infectious Disease | 69 (43–98) | 448 | 1 | ≈$3,290 | Hybrid | 0.0 |
| Acta Crystallographica Section F Structural Biology Communications | 69 (51–100) | 64 | 16 | ≈$3,520 | — | 0.0 |
| Frontiers in Plant Science | 70 (49–104) | 3,153 | 24 | ≈$3,850 | Open access (DOAJ) | 0.55 |
| Naunyn-Schmiedeberg s Archives of Pharmacology | 70 (43–114) | 1,122 | 19 | ≈$4,790 | — | 17.86 |
| RSC Medicinal Chemistry | 70 (50–95) | 372 | 6 | — | Hybrid | 0.0 |
| Marine Biotechnology | 70 (54–114) | 155 | 17 | ≈$3,790 | Hybrid | 0.0 |
| Frontiers in Molecular Neuroscience | 70 (47–109) | 155 | 22 | ≈$3,850 | Open access (DOAJ) | 1.02 |
| The Plant Pathology Journal | 70 (46–100) | 71 | 56 | $850 | Open access (DOAJ) | 0.0 |
| Iranian Journal of Biotechnology | 70 (38–146) | 57 | 94 | — | Open access | 0.0 |
| IET Systems Biology | 70 (50–93) | 56 | — | $2,400 | Open access (DOAJ) | — |
| Bioelectrochemistry | 71 (51–92) | 266 | 2 | ≈$3,970 | — | 0.0 |
| Genetics | 71 (42–116) | 256 | — | ≈$4,477 | Hybrid | 0.0 |
| MycoKeys | 71 (49–90) | 199 | 29 | ≈$1,096 | Open access (DOAJ) | 0.0 |
| Combinatorial Chemistry & High Throughput Screening | 71 (54–94) | 192 | 136 | — | — | 0.0 |
| Current Opinion in Microbiology | 71 (50–107) | 69 | 21 | ≈$3,800 | Hybrid | 0.0 |
| Genes Chromosomes and Cancer | 71 (44–109) | 68 | — | ≈$4,810 | — | 0.0 |
| Toxicon | 72 (49–104) | 342 | 2 | ≈$3,340 | — | 0.0 |
| Bioorganic Chemistry | 73 (52–104) | 1,192 | 2 | ≈$4,240 | Hybrid | 0.23 |
| G3 Genes Genomes Genetics | 73 (47–113) | 307 | — | $2,580 | Open access (DOAJ) | 0.0 |
| Bioorganic & Medicinal Chemistry Letters | 73 (54–104) | 304 | 2 | ≈$3,880 | Hybrid | 0.57 |
| Anti-Cancer Agents in Medicinal Chemistry | 73 (57–96) | 197 | 161 | — | — | 0.0 |
| Cancer Genetics | 73 (44–102) | 113 | 1 | ≈$3,320 | — | 0.0 |
| Natural Products and Bioprospecting | 73 (49–99) | 90 | 43 | $2,590 | Open access (DOAJ) | 0.0 |
| Biomedicine & Pharmacotherapy | 74 (57–97) | 998 | 6 | ≈$3,610 | Open access | 2.37 |
| Frontiers in Bioscience-Landmark | 74 (59–91) | 328 | — | $2,500 | Open access (DOAJ) | 0.0 |
| PhytoKeys | 74 (50–115) | 261 | 29 | ≈$900 | Open access (DOAJ) | 0.0 |
| Trends in Biochemical Sciences | 74 (15–95) | 121 | 28 | ≈$7,030 | — | 0.0 |
| Nitric Oxide | 74 (48–111) | 58 | 1 | ≈$3,400 | Hybrid | 0.0 |
| Pharmacological Research | 75 (55–103) | 424 | 2 | $4,510 | Open access (DOAJ) | 0.0 |
| Frontiers in Bioinformatics | 75 (57–111) | 175 | 24 | ≈$3,117 | Open access (DOAJ) | 0.0 |
| Mammalian Genome | 75 (50–104) | 86 | 17 | ≈$3,890 | — | 22.51 |
| Journal of Biophotonics | 76 (54–100) | 241 | 18 | ≈$3,370 | Hybrid | 0.0 |
| Journal of Plant Physiology | 76 (55–115) | 162 | 1 | ≈$3,370 | — | 0.0 |
| Mechanisms of Ageing and Development | 76 (61–105) | 75 | 2 | ≈$4,780 | Hybrid | 0.0 |
| SLAS DISCOVERY | 76 (55–117) | 74 | 1 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Protein & Cell | 76 (45–141) | 68 | — | $2,570 | Open access (DOAJ) | 0.0 |
| Molecular Biology Reports | 77 (57–111) | 1,169 | 11 | ≈$4,290 | Hybrid | 1.74 |
| World Journal of Microbiology and Biotechnology | 77 (56–112) | 523 | 19 | ≈$4,090 | Hybrid | 0.57 |
| Synthetic and Systems Biotechnology | 77 (58–92) | 176 | 4 | $1,500 | Open access (DOAJ) | 0.0 |
| AMB Express | 77 (56–120) | 173 | 23 | $3,090 | Open access (DOAJ) | 1.25 |
| Biology Direct | 77 (45–115) | 127 | 16 | $2,990 | Open access (DOAJ) | 0.0 |
| Biophysical Chemistry | 77 (56–107) | 92 | 2 | ≈$3,720 | — | 0.0 |
| Genes & Genomics | 78 (41–108) | 115 | 25 | ≈$2,390 | — | 1.51 |
| IMA Fungus | 78 (59–105) | 83 | 28 | ≈$2,250 | Open access (DOAJ) | — |
| Matrix Biology | 78 (52–115) | 57 | 1 | ≈$4,280 | Hybrid | 0.0 |
| Frontiers in Pharmacology | 79 (53–120) | 3,916 | 19 | ≈$3,850 | Open access (DOAJ) | 0.66 |
| Neoplasia | 79 (43–117) | 133 | 8 | $3,790 | Open access (DOAJ) | 1.88 |
| In Vitro Cellular & Developmental Biology - Animal | 79 (53–121) | 130 | 58 | ≈$2,490 | — | 0.0 |
| Current Drug Targets | 79 (66–107) | 95 | — | — | — | 2.47 |
| Biology Methods and Protocols | 79 (44–110) | 90 | 3 | $1,067 | Open access (DOAJ) | 0.0 |
| Molecules and Cells | 79 (63–108) | 63 | 5 | $2,500 | Open access (DOAJ) | 0.0 |
| Frontiers in Cellular and Infection Microbiology | 80 (53–115) | 1,483 | 22 | ≈$3,850 | Open access (DOAJ) | 0.28 |
| Data in Brief | 80 (50–127) | 1,145 | 7 | $1,330 | Open access (DOAJ) | 0.0 |
| RSC Chemical Biology | 80 (53–110) | 167 | 3 | ≈$2,831 | Open access (DOAJ) | 0.0 |
| Vavilov Journal of Genetics and Breeding | 80 (54–123) | 131 | — | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Steroids | 80 (52–105) | 85 | 2 | ≈$3,760 | — | 2.08 |
| Medical Oncology | 81 (67–106) | 603 | 16 | ≈$4,290 | — | 4.27 |
| Clinical Chemistry | 81 (27–116) | 178 | — | ≈$4,636 | Hybrid | 0.0 |
| The Journal of Steroid Biochemistry and Molecular Biology | 81 (56–121) | 177 | 1 | ≈$3,980 | — | 0.0 |
| Methods | 81 (56–115) | 157 | 2 | ≈$3,600 | — | 0.0 |
| Biomolecules & Therapeutics | 81 (43–109) | 81 | 33 | — | — | 0.0 |
| Glycobiology | 81 (50–138) | 75 | — | ≈$4,756 | Hybrid | 0.0 |
| Analytical Biochemistry | 82 (55–116) | 188 | 1 | ≈$3,540 | Hybrid | 0.0 |
| Trends in Plant Science | 82 (48–136) | 185 | 24 | ≈$7,030 | Hybrid | 0.0 |
| Molecular Genetics and Metabolism | 82 (57–118) | 171 | 4 | ≈$3,680 | Hybrid | 0.0 |
| Chinese Journal of Cancer Research | 82 (47–105) | 73 | — | — | Open access | 0.0 |
| FEBS Letters | 83 (55–116) | 265 | 32 | ≈$3,980 | Hybrid | 0.91 |
| BioData Mining | 83 (58–151) | 89 | 17 | $2,790 | Open access (DOAJ) | 0.0 |
| Biosensors and Bioelectronics | 84 (61–119) | 1,023 | 1 | ≈$5,540 | Hybrid | 0.23 |
| Computational Biology and Chemistry | 84 (59–120) | 462 | 4 | ≈$3,320 | — | 0.0 |
| Functional & Integrative Genomics | 84 (61–117) | 280 | 20 | ≈$2,690 | — | 24.92 |
| Breast Cancer Research and Treatment | 84 (57–127) | 266 | 17 | ≈$4,190 | Hybrid | 0.0 |
| Photochemistry and Photobiology | 84 (58–129) | 128 | 21 | ≈$4,330 | — | 0.0 |
| Journal of Basic Microbiology | 84 (66–108) | 125 | 17 | ≈$3,240 | — | 0.0 |
| Journal of Natural Medicines | 84 (53–114) | 119 | 28 | ≈$4,590 | — | 0.0 |
| Current Opinion in Plant Biology | 84 (62–120) | 105 | 25 | ≈$4,810 | Hybrid | 0.0 |
| IUBMB Life | 84 (59–146) | 77 | — | ≈$4,430 | Hybrid | 0.0 |
| Neurochemical Research | 85 (62–129) | 314 | 16 | ≈$4,590 | — | 0.73 |
| Journal of Microbiological Methods | 85 (56–123) | 226 | 2 | ≈$3,120 | Hybrid | 0.0 |
| Biotechnology for Biofuels and Bioproducts | 85 (66–118) | 128 | 20 | $2,990 | Open access (DOAJ) | 0.0 |
| Journal of Human Genetics | 85 (48–131) | 127 | 15 | ≈$5,490 | — | 0.0 |
| American Journal of Cancer Research | 86 (57–130) | 332 | 13 | — | — | 2.11 |
| Biosystems | 86 (56–133) | 187 | 3 | ≈$2,870 | Hybrid | 0.0 |
| International Microbiology | 86 (59–118) | 141 | 15 | ≈$3,290 | — | 0.0 |
| Journal of Molecular Biology | 87 (58–121) | 409 | 4 | ≈$4,730 | Hybrid | 0.0 |
| Microbiological Research | 87 (61–126) | 282 | 2 | ≈$4,470 | Hybrid | 0.0 |
| Neurochemistry International | 87 (64–120) | 134 | 1 | ≈$4,170 | — | 0.0 |
| Intestinal Research | 87 (64–118) | 76 | 80 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| ACS Bio & Med Chem Au | 87 (73–110) | 64 | 12 | $3,500 | Open access (DOAJ) | 0.0 |
| TURKISH JOURNAL OF BIOLOGY | 87 (65–110) | 54 | 0 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Photosynthesis Research | 87 (63–121) | 54 | 12 | ≈$3,890 | — | 2.89 |
| Frontiers in Genetics | 88 (60–132) | 880 | 20 | ≈$3,850 | Open access (DOAJ) | 1.31 |
| Fitoterapia | 88 (66–118) | 604 | 2 | ≈$3,950 | — | 0.0 |
| Molecular Cancer | 88 (57–131) | 301 | 29 | $5,290 | Open access (DOAJ) | 0.0 |
| Drug Resistance Updates | 89 (62–122) | 94 | 3 | ≈$5,410 | — | 0.0 |
| Anaerobe | 89 (67–121) | 75 | 4 | ≈$3,350 | — | 0.0 |
| Purinergic Signalling | 89 (26–146) | 55 | 20 | ≈$4,690 | — | 3.19 |
| PLANT PHYSIOLOGY | 90 (30–146) | 670 | — | ≈$3,851 | Hybrid | 0.32 |
| Insect Biochemistry and Molecular Biology | 90 (61–123) | 142 | 2 | ≈$4,210 | Hybrid | 0.0 |
| Current Pharmaceutical Biotechnology | 90 (64–110) | 141 | 127 | — | — | 0.0 |
| Computational and Structural Biotechnology Journal | 91 (67–116) | 556 | 3 | ≈$3,404 | Open access (DOAJ) | 0.0 |
| Pathology - Research and Practice | 91 (59–142) | 412 | 1 | ≈$2,780 | — | 0.82 |
| ACS Pharmacology & Translational Science | 91 (63–129) | 289 | 10 | ≈$4,500 | Hybrid | 0.0 |
| Stem Cell Research | 91 (52–151) | 246 | 2 | $2,460 | Open access (DOAJ) | 0.59 |
| Human Genomics | 91 (57–152) | 174 | 23 | $3,390 | Open access (DOAJ) | 0.0 |
| Current Opinion in Structural Biology | 91 (69–107) | 162 | 26 | ≈$4,360 | Hybrid | 1.34 |
| Enzyme and Microbial Technology | 91 (71–123) | 153 | 2 | ≈$3,700 | — | 0.0 |
| Trends in Cell Biology | 91 (71–111) | 86 | 27 | ≈$7,030 | Hybrid | 0.0 |
| Protein and Peptide Letters | 91 (78–109) | 68 | — | — | — | 0.0 |
| Cancer Letters | 92 (67–128) | 511 | 1 | ≈$4,960 | Hybrid | 0.96 |
| Journal of Pediatric Endocrinology and Metabolism | 92 (68–138) | 175 | 18 | ≈$2,712 | Hybrid | 0.0 |
| Cell Proliferation | 92 (67–135) | 138 | 16 | $3,680 | Open access (DOAJ) | 0.0 |
| Legal Medicine | 92 (62–137) | 133 | 2 | ≈$3,540 | — | 3.09 |
| The Journal of Antibiotics | 92 (62–129) | 76 | 21 | ≈$4,590 | — | 4.51 |
| Journal of Translational Medicine | 93 (66–131) | 1,502 | 25 | $4,090 | Open access (DOAJ) | 0.22 |
| Chemico-Biological Interactions | 93 (68–142) | 369 | 1 | ≈$3,540 | Hybrid | 1.15 |
| Science China Life Sciences | 93 (55–136) | 306 | 81 | ≈$3,790 | — | 0.0 |
| Drug Discovery Today | 93 (66–146) | 264 | 4 | ≈$4,720 | — | 0.0 |
| The Breast | 93 (66–129) | 213 | 2 | $3,770 | Open access (DOAJ) | 0.0 |
| Clinical Breast Cancer | 93 (69–143) | 197 | 4 | ≈$3,470 | — | 0.0 |
| Probiotics and Antimicrobial Proteins | 93 (70–140) | 194 | 15 | ≈$4,090 | Hybrid | 0.0 |
| Bioprocess and Biosystems Engineering | 93 (66–128) | 154 | 16 | ≈$4,090 | — | 2.59 |
| Food Chemistry Molecular Sciences | 93 (76–126) | 113 | 2 | $2,730 | Open access (DOAJ) | 0.0 |
| Journal of Bioscience and Bioengineering | 93 (70–126) | 111 | 24 | ≈$3,000 | — | 0.0 |
| Biological Procedures Online | 93 (54–125) | 62 | 29 | $3,590 | Open access (DOAJ) | — |
| Plant Physiology and Biochemistry | 94 (65–138) | 1,367 | 1 | ≈$3,990 | Hybrid | 0.75 |
| STAR Protocols | 94 (71–122) | 720 | 22 | $1,920 | Open access (DOAJ) | 0.0 |
| Cellular Signalling | 94 (68–130) | 641 | 2 | ≈$3,550 | Hybrid | 2.1 |
| Bioresources and Bioprocessing | 94 (77–124) | 162 | 23 | $1,990 | Open access (DOAJ) | 1.63 |
| Journal of Biological Engineering | 94 (63–136) | 139 | 17 | $3,090 | Open access (DOAJ) | 0.0 |
| RNA | 94 (45–141) | 118 | 74 | — | Hybrid | 1.59 |
| Current Opinion in Cell Biology | 94 (68–122) | 100 | 25 | ≈$4,390 | Hybrid | 0.0 |
| Neurogenetics | 94 (64–147) | 75 | 15 | ≈$4,590 | — | 4.48 |
| Cell Calcium | 94 (67–150) | 51 | 1 | ≈$3,950 | — | 0.0 |
| Journal of Molecular Histology | 95 (59–143) | 350 | 25 | ≈$3,890 | — | 1.41 |
| Microbial Cell Factories | 95 (69–144) | 270 | 18 | $3,690 | Open access (DOAJ) | 1.46 |
| Mini-Reviews in Medicinal Chemistry | 95 (76–110) | 151 | — | — | — | 0.0 |
| Letters in Applied Microbiology | 95 (76–139) | 141 | — | ≈$3,240 | — | 0.0 |
| Neuromuscular Disorders | 95 (69–131) | 104 | 1 | ≈$3,470 | — | 1.75 |
| Molecular Genetics and Metabolism Reports | 95 (62–139) | 100 | 7 | $2,620 | Open access (DOAJ) | 0.0 |
| Current Protein and Peptide Science | 95 (75–116) | 82 | 138 | — | — | 0.0 |
| Biopolymers | 95 (49–125) | 81 | — | ≈$4,150 | — | 0.0 |
| Acta Crystallographica Section D Structural Biology | 95 (75–155) | 61 | 20 | ≈$5,230 | Hybrid | 0.0 |
| Cell Host & Microbe | 96 (6–180) | 201 | 24 | ≈$10,400 | Hybrid | 0.0 |
| Journal of genetics and genomics/Journal of Genetics and Genomics | 96 (66–130) | 126 | 7 | ≈$3,140 | — | 0.0 |
| FASEB BioAdvances | 96 (60–129) | 78 | 21 | $3,170 | Open access (DOAJ) | 0.0 |
| Familial Cancer | 96 (64–124) | 74 | 21 | ≈$2,990 | — | 0.0 |
| Cancer Drug Resistance | 96 (69–117) | 63 | 12 | — | Open access | 0.0 |
| Molecular Aspects of Medicine | 96 (45–125) | 60 | 8 | ≈$5,220 | — | 0.0 |
| The Journal of Gene Medicine | 96 (71–139) | 59 | — | ≈$4,480 | — | 2.26 |
| Fungal Genetics and Biology | 96 (74–125) | 54 | 5 | ≈$3,210 | — | 0.0 |
| Chemistry & Biodiversity | 97 (69–130) | 1,350 | 17 | ≈$3,880 | — | 0.5 |
| Gene | 97 (70–133) | 475 | 2 | ≈$3,300 | — | 0.0 |
| Journal of Integrative Plant Biology | 97 (50–173) | 264 | 30 | ≈$3,000 | — | 0.0 |
| Journal of Cancer | 97 (73–133) | 246 | 21 | ≈$2,850 | Open access (DOAJ) | 0.92 |
| Drug Development Research | 97 (65–150) | 167 | — | ≈$3,980 | — | 1.53 |
| Clinical & Experimental Metastasis | 97 (73–158) | 61 | 21 | ≈$5,090 | — | 0.0 |
| Frontiers in Microbiomes | 97 (64–150) | 59 | 23 | ≈$2,383 | Open access (DOAJ) | — |
| General Physiology and Biophysics | 97 (74–141) | 53 | — | — | Open access | 0.0 |
| JNCI Journal of the National Cancer Institute | 98 (15–150) | 350 | — | ≈$5,436 | Hybrid | 0.9 |
| Food Microbiology | 98 (75–120) | 232 | 1 | ≈$4,210 | Hybrid | 0.0 |
| Biotechnology Journal | 98 (70–128) | 190 | — | ≈$4,780 | — | 0.0 |
| DNA repair | 98 (66–133) | 92 | 3 | ≈$3,390 | Hybrid | 2.07 |
| International Journal of Oncology | 98 (74–133) | 86 | 34 | — | Hybrid | 3.6 |
| Current Opinion in Genetics & Development | 98 (74–131) | 75 | 22 | ≈$4,200 | Hybrid | 0.0 |
| Current Gene Therapy | 98 (71–124) | 71 | 124 | — | — | 0.0 |
| Frontiers in Oncology | 99 (66–148) | 4,517 | 21 | ≈$3,850 | Open access (DOAJ) | 2.04 |
| Archives of Biochemistry and Biophysics | 99 (61–144) | 314 | 1 | ≈$3,170 | Hybrid | 2.33 |
| Microbial Biotechnology | 99 (61–152) | 196 | — | $4,260 | Open access (DOAJ) | 0.0 |
| Plant Methods | 99 (72–148) | 168 | 18 | $3,190 | Open access (DOAJ) | 0.0 |
| Rice | 99 (73–138) | 119 | 18 | $3,190 | Open access (DOAJ) | 2.41 |
| Current Molecular Medicine | 99 (76–126) | 116 | 145 | — | — | 0.0 |
| Trends in Molecular Medicine | 99 (56–141) | 111 | 25 | ≈$7,030 | Hybrid | 0.0 |
| Extracellular Vesicles and Circulating Nucleic Acids | 99 (81–129) | 72 | 19 | — | — | — |
| Cytotechnology | 100 (61–148) | 174 | 14 | ≈$4,190 | — | 2.39 |
| SLAS TECHNOLOGY | 100 (80–133) | 123 | 1 | $2,380 | Open access (DOAJ) | 0.0 |
| Journal of Structural Biology | 100 (70–154) | 84 | 2 | ≈$4,350 | Hybrid | 0.0 |
| Theranostics | 101 (64–128) | 566 | 24 | ≈$3,206 | Open access (DOAJ) | 0.0 |
| Journal of Experimental & Clinical Cancer Research | 101 (73–131) | 327 | 17 | $4,490 | Open access (DOAJ) | 5.19 |
| APOPTOSIS | 101 (72–147) | 82 | 27 | ≈$5,090 | Hybrid | 1.95 |
| Journal of Controlled Release | 102 (76–135) | 1,020 | 2 | ≈$4,440 | Hybrid | 0.28 |
| Infection and Drug Resistance | 102 (82–124) | 593 | 12 | $4,320 | Open access (DOAJ) | 0.97 |
| American Journal of Medical Genetics Part A | 102 (67–145) | 342 | 13 | ≈$4,710 | — | 0.0 |
| Planta | 102 (66–151) | 302 | 14 | ≈$4,590 | Hybrid | 1.5 |
| Frontiers in Aging | 102 (69–155) | 194 | 20 | ≈$3,117 | Open access (DOAJ) | 0.0 |
| Biochimie | 102 (68–155) | 170 | 1 | ≈$3,110 | Hybrid | 0.0 |
| Biomarker Research | 102 (71–137) | 121 | 17 | $4,090 | Open access (DOAJ) | 0.0 |
| Gut Pathogens | 102 (73–154) | 111 | 22 | $3,390 | Open access (DOAJ) | 2.68 |
| Pflügers Archiv - European Journal of Physiology | 102 (66–146) | 74 | 18 | ≈$4,390 | — | 0.0 |
| Microscopy | 102 (55–137) | 59 | — | ≈$3,494 | — | 0.0 |
| Journal of Computer-Aided Molecular Design | 103 (80–135) | 174 | 20 | ≈$4,190 | — | 0.0 |
| BMC Biotechnology | 103 (71–156) | 148 | 18 | $3,090 | Open access (DOAJ) | 0.0 |
| Journal of Cell Communication and Signaling | 103 (70–173) | 54 | 23 | ≈$2,860 | — | 0.0 |
| Korean Journal of Physiology and Pharmacology | 103 (67–147) | 53 | — | — | Open access | 0.0 |
| BMC Plant Biology | 104 (72–161) | 1,992 | 21 | $3,190 | Open access (DOAJ) | 0.0 |
| International Journal of Medical Sciences | 104 (74–137) | 357 | 20 | ≈$1,425 | Open access (DOAJ) | 0.0 |
| Diabetologia | 104 (77–141) | 244 | 70 | ≈$3,490 | Hybrid | 0.97 |
| International Journal of Molecular Medicine | 104 (80–131) | 219 | 32 | — | Hybrid | 12.55 |
| Journal of Genetic Engineering and Biotechnology | 104 (70–170) | 191 | 13 | $1,000 | Open access (DOAJ) | 0.0 |
| Human Molecular Genetics | 104 (71–152) | 177 | — | ≈$4,390 | Hybrid | 0.0 |
| Journal of Proteomics | 104 (75–150) | 119 | 2 | ≈$3,570 | Hybrid | 0.0 |
| Biofilm | 104 (78–144) | 85 | 1 | $3,200 | Open access (DOAJ) | 0.0 |
| Biochemical Pharmacology | 105 (82–136) | 753 | 1 | ≈$3,590 | Hybrid | 0.4 |
| Biochemistry and Biophysics Reports | 105 (74–154) | 514 | 6 | $2,750 | Open access (DOAJ) | 0.0 |
| Plant Science | 105 (76–143) | 476 | 2 | ≈$3,760 | — | 0.0 |
| Journal of Food Protection | 105 (75–144) | 236 | 4 | $2,600 | Open access (DOAJ) | 0.0 |
| Molecular Plant | 105 (30–179) | 223 | 3 | ≈$5,000 | Hybrid | 0.0 |
| Metabolic Engineering | 105 (80–135) | 144 | 1 | ≈$4,780 | Hybrid | 0.0 |
| Molecular Carcinogenesis | 105 (70–143) | 127 | 19 | ≈$4,490 | — | 0.0 |
| FEMS Yeast Research | 105 (72–163) | 72 | — | ≈$3,371 | Open access (DOAJ) | 0.0 |
| Biotechnology and Bioengineering | 106 (79–140) | 262 | 13 | ≈$5,060 | — | 0.0 |
| Phytochemical Analysis | 106 (72–138) | 85 | 13 | ≈$4,380 | — | 0.0 |
| International Journal of Food Microbiology | 107 (83–140) | 404 | 2 | ≈$4,090 | Hybrid | 1.27 |
| Current Medicinal Chemistry | 107 (79–142) | 402 | 146 | — | — | 0.0 |
| Applied Microbiology and Biotechnology | 107 (75–153) | 290 | 21 | $4,390 | Open access (DOAJ) | 0.39 |
| Journal of Pharmacology and Experimental Therapeutics | 107 (75–153) | 223 | 7 | ≈$3,750 | Hybrid | 0.0 |
| Biochemical Journal | 107 (69–149) | 115 | 19 | — | — | 0.0 |
| International Journal of Genomics | 107 (71–173) | 96 | 34 | $2,620 | Open access (DOAJ) | 0.0 |
| Experimental Cell Research | 108 (75–154) | 299 | 2 | ≈$3,270 | — | 0.68 |
| Translational Cancer Research | 109 (79–135) | 625 | 65 | — | Open access | 1.37 |
| Cancer Management and Research | 109 (86–140) | 278 | 14 | $3,940 | Open access (DOAJ) | 18.57 |
| Molecular and Cellular Biochemistry | 109 (81–152) | 250 | 15 | ≈$4,190 | — | 7.44 |
| Journal of Biotechnology | 109 (85–143) | 221 | 2 | ≈$4,360 | — | 0.0 |
| Journal of Inherited Metabolic Disease | 109 (78–150) | 130 | — | ≈$3,470 | — | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 109 (78–147) | 115 | 2 | ≈$3,670 | Hybrid | 0.0 |
| Physiologia Plantarum | 110 (80–161) | 652 | — | ≈$4,150 | — | 0.52 |
| Experimental Eye Research | 110 (78–159) | 462 | 1 | ≈$4,010 | Hybrid | 0.57 |
| Antonie van Leeuwenhoek | 110 (75–146) | 179 | 16 | ≈$3,690 | — | 0.0 |
| Breast Cancer Targets and Therapy | 110 (85–142) | 107 | 13 | $4,320 | Open access (DOAJ) | 0.0 |
| Journal of Eukaryotic Microbiology | 110 (66–158) | 54 | — | ≈$3,090 | — | 0.0 |
| International Journal of Medical Microbiology | 110 (87–157) | 51 | 2 | $3,480 | Open access (DOAJ) | — |
| Cell Communication and Signaling | 111 (79–150) | 609 | 17 | $3,490 | Open access (DOAJ) | 0.0 |
| Journal of Applied Microbiology | 111 (77–167) | 318 | — | ≈$3,777 | Hybrid | 0.0 |
| Chinese Medicine | 111 (80–148) | 255 | 24 | $3,090 | Open access (DOAJ) | 0.0 |
| Molecular and Cellular Endocrinology | 111 (77–148) | 145 | 1 | ≈$3,510 | — | 0.0 |
| Brain and Development | 111 (71–151) | 139 | 12 | ≈$2,810 | — | 0.0 |
| Oncology Reports | 111 (91–142) | 132 | 38 | — | Hybrid | 11.26 |
| World Journal of Stem Cells | 111 (88–142) | 124 | — | — | Hybrid | 0.0 |
| PROTOPLASMA | 111 (72–151) | 115 | 14 | ≈$3,690 | — | 0.0 |
| Annals of Clinical Microbiology and Antimicrobials | 111 (79–169) | 73 | 20 | $3,290 | Open access (DOAJ) | 0.0 |
| ZOOLOGICAL SCIENCE | 111 (67–169) | 62 | — | — | — | 0.0 |
| Systematic and Applied Microbiology | 111 (70–150) | 57 | 2 | ≈$4,010 | — | 0.0 |
| Journal of Biological Chemistry | 112 (70–163) | 1,252 | 7 | $3,430 | Open access (DOAJ) | 0.0 |
| Journal of Global Antimicrobial Resistance | 112 (73–154) | 241 | 7 | $1,890 | Open access (DOAJ) | 0.0 |
| FEMS Microbiology Letters | 112 (73–171) | 148 | — | ≈$3,297 | — | 0.0 |
| Non-coding RNA Research | 112 (84–152) | 93 | 2 | $1,100 | Open access (DOAJ) | 0.0 |
| The Journal of Physiology | 113 (50–170) | 613 | 24 | ≈$5,400 | Hybrid | 0.0 |
| Acta Pharmaceutica Sinica B | 113 (87–148) | 415 | 60 | $2,600 | Open access (DOAJ) | 0.0 |
| Journal of Lipid Research | 113 (75–194) | 187 | 3 | $3,860 | Open access (DOAJ) | 0.0 |
| Advanced Drug Delivery Reviews | 113 (84–160) | 131 | 3 | ≈$5,550 | — | 0.0 |
| Journal of Medical Genetics | 113 (78–148) | 116 | 87 | — | Hybrid | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics | 113 (85–141) | 57 | 1 | ≈$3,900 | — | 0.0 |
| The FASEB Journal | 114 (87–152) | 1,048 | — | ≈$3,740 | Hybrid | 1.36 |
| The Kaohsiung Journal of Medical Sciences | 114 (77–157) | 134 | 28 | $1,320 | Open access (DOAJ) | 0.0 |
| Biotechnology Reports | 114 (81–152) | 67 | 1 | $3,630 | Open access (DOAJ) | 0.0 |
| Frontiers of Medicine | 114 (73–140) | 58 | 114 | ≈$2,390 | — | 0.0 |
| International Journal of Biological Sciences | 115 (84–157) | 398 | 22 | ≈$1,425 | Open access (DOAJ) | 0.56 |
| Breast Cancer | 115 (78–153) | 139 | 13 | ≈$3,890 | — | 0.0 |
| Journal of Microscopy | 115 (74–156) | 102 | 14 | ≈$4,760 | — | 0.0 |
| Seminars in Cancer Biology | 115 (77–178) | 91 | 5 | ≈$6,060 | — | 0.0 |
| Protein Science | 116 (89–153) | 416 | — | ≈$4,480 | Hybrid | 0.66 |
| Clinical and Translational Medicine | 116 (85–152) | 313 | — | $3,640 | Open access (DOAJ) | 1.59 |
| Genes & Development | 116 (80–154) | 87 | 129 | — | Open access | 0.0 |
| Mobile DNA | 116 (73–145) | 51 | 21 | $3,190 | Open access (DOAJ) | — |
| Plant Biotechnology Journal | 117 (80–176) | 571 | 20 | $4,750 | Open access (DOAJ) | 0.0 |
| Trends in biotechnology | 117 (74–179) | 273 | 29 | ≈$7,030 | — | 0.0 |
| Animal Models and Experimental Medicine | 117 (84–172) | 160 | 41 | $2,000 | Open access (DOAJ) | 0.0 |
| Cellular Oncology | 117 (90–149) | 105 | 34 | $2,380 | Open access (DOAJ) | 1.88 |
| BMC Genomic Data | 117 (85–167) | 104 | 21 | $2,290 | Open access (DOAJ) | 0.0 |
| Briefings in Bioinformatics | 118 (87–155) | 738 | — | $3,885 | Open access (DOAJ) | 0.0 |
| Molecular Breeding | 118 (69–165) | 95 | 20 | ≈$3,990 | — | 0.0 |
| Journal of Biomedical Science | 118 (88–172) | 90 | 22 | No fee (DOAJ) | Open access (DOAJ) | 2.07 |
| Phytomedicine | 119 (88–160) | 1,365 | 2 | ≈$3,630 | — | 0.24 |
| Journal of Antimicrobial Chemotherapy | 119 (89–163) | 363 | — | ≈$3,784 | Hybrid | 0.95 |
| Folia Microbiologica | 119 (60–166) | 178 | 19 | ≈$2,590 | Hybrid | 0.0 |
| npj Aging | 119 (88–171) | 128 | 22 | ≈$3,690 | — | 0.0 |
| OncoTargets and Therapy | 119 (98–150) | 95 | 12 | ≈$2,836 | Open access | 14.89 |
| Cancer Science | 120 (83–148) | 276 | 15 | $2,600 | Open access (DOAJ) | 1.74 |
| Cell & Bioscience | 120 (93–161) | 179 | 19 | $2,990 | Open access (DOAJ) | 1.05 |
| FEBS Open Bio | 120 (83–160) | 178 | 14 | $2,480 | Open access (DOAJ) | 5.47 |
| American Journal Of Pathology | 120 (80–167) | 169 | 27 | ≈$2,800 | Hybrid | 0.0 |
| Acta Botanica Yunnanica | 120 (91–160) | 95 | 6 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Science & Justice | 120 (94–164) | 80 | 2 | ≈$3,720 | — | 0.0 |
| Horticulture Research | 121 (97–156) | 328 | 10 | $2,960 | Open access (DOAJ) | 0.66 |
| Epigenetics & Chromatin | 121 (96–161) | 88 | 19 | $3,290 | Open access (DOAJ) | 0.0 |
| Carcinogenesis | 121 (88–183) | 82 | — | ≈$4,835 | — | 2.21 |
| Biochimica et Biophysica Acta (BBA) - Biomembranes | 121 (82–166) | 71 | 3 | ≈$3,870 | Hybrid | 0.0 |
| aBIOTECH | 121 (88–135) | 55 | 21 | ≈$2,190 | — | — |
| European Journal of Pharmacology | 122 (90–162) | 1,009 | 1 | ≈$3,230 | — | 0.0 |
| BMC Microbiology | 122 (85–186) | 945 | 27 | $3,090 | Open access (DOAJ) | 0.4 |
| The ISME Journal | 122 (83–167) | 288 | — | ≈$4,241 | Open access (DOAJ) | 0.0 |
| Journal of Community Genetics | 122 (93–184) | 83 | 18 | ≈$3,990 | — | 0.0 |
| Biological Research | 122 (82–220) | 78 | 20 | $2,890 | Open access (DOAJ) | 0.0 |
| European Biophysics Journal | 122 (81–178) | 71 | 24 | ≈$2,490 | — | 0.0 |
| Cancer and Metastasis Reviews | 122 (99–164) | 69 | 13 | ≈$3,790 | — | 0.0 |
| Biochimica et Biophysica Acta (BBA) - General Subjects | 123 (86–165) | 133 | 3 | ≈$3,310 | Hybrid | 0.0 |
| Human Mutation | 123 (73–189) | 119 | 35 | ≈$2,740 | Hybrid | 0.0 |
| Acta Pharmacologica Sinica | 124 (97–153) | 252 | 37 | ≈$4,390 | Hybrid | 0.0 |
| Animal Genetics | 124 (80–182) | 59 | — | ≈$3,570 | Hybrid | 0.0 |
| Stem Cell Research & Therapy | 125 (88–174) | 727 | 21 | $3,290 | Open access (DOAJ) | 4.57 |
| Journal of Advanced Research | 125 (88–176) | 717 | 3 | $4,400 | Open access (DOAJ) | 0.57 |
| Oncology Letters | 125 (98–155) | 508 | 33 | — | Open access | 6.38 |
| Biomedical Reports | 125 (98–166) | 175 | 27 | — | Open access | 0.0 |
| Proteins Structure Function and Bioinformatics | 125 (92–168) | 159 | 14 | ≈$4,550 | — | 0.0 |
| Acta Physiologica | 125 (77–186) | 130 | — | ≈$5,150 | Hybrid | 0.0 |
| Fungal Biology | 125 (81–173) | 117 | 1 | ≈$2,500 | — | 0.0 |
| BioEssays | 125 (75–158) | 103 | 14 | ≈$5,330 | — | 0.0 |
| Discover Oncology | 126 (95–170) | 2,564 | 13 | $2,390 | Open access (DOAJ) | 0.53 |
| Bioinformatics Advances | 126 (91–161) | 325 | 4 | $2,620 | Open access (DOAJ) | 0.0 |
| The Plant Genome | 126 (93–174) | 187 | — | $3,520 | Open access (DOAJ) | 0.0 |
| Plant and Cell Physiology | 126 (90–185) | 171 | — | ≈$3,085 | Hybrid | 1.26 |
| Cell Biology International | 126 (90–193) | 129 | 15 | ≈$3,730 | — | 2.58 |
| BMC Research Notes | 127 (82–214) | 525 | 15 | $1,790 | Open access (DOAJ) | 0.0 |
| Biophysical Journal | 127 (92–170) | 429 | 3 | ≈$3,000 | Hybrid | 0.0 |
| Cancer Epidemiology Biomarkers & Prevention | 127 (102–167) | 253 | — | — | Hybrid | 0.0 |
| Forensic Science International Genetics | 127 (90–170) | 131 | 2 | ≈$5,020 | — | 0.0 |
| Molecular Pharmacology | 127 (95–160) | 74 | 7 | ≈$3,600 | Hybrid | 0.0 |
| Journal of Experimental Zoology Part B Molecular and Developmental Evolution | 127 (34–200) | 54 | 16 | ≈$3,460 | — | 0.0 |
| Molecular Biotechnology | 128 (88–191) | 171 | 26 | ≈$3,790 | — | 0.0 |
| Molecular Microbiology | 128 (91–183) | 74 | 15 | ≈$4,430 | Hybrid | 0.0 |
| Biotechnology Advances | 129 (92–162) | 215 | 2 | ≈$5,460 | — | 0.0 |
| Mitochondrion | 129 (95–173) | 61 | 2 | ≈$3,220 | — | 0.0 |
| Microbial Pathogenesis | 130 (88–196) | 908 | 1 | ≈$3,140 | — | 0.33 |
| Clinical Epigenetics | 130 (85–190) | 233 | 25 | $3,890 | Open access (DOAJ) | 0.99 |
| BMC Medical Genomics | 130 (91–242) | 214 | 22 | $3,290 | Open access (DOAJ) | 1.43 |
| Cell Biology and Toxicology | 130 (100–161) | 144 | 25 | ≈$4,190 | — | 0.0 |
| 3 Biotech | 131 (91–185) | 493 | 21 | ≈$4,090 | — | 0.97 |
| Cellular and Molecular Life Sciences | 131 (91–189) | 479 | 37 | $4,390 | Open access (DOAJ) | 0.0 |
| Molecular Medicine | 131 (82–190) | 335 | 18 | $3,290 | Open access (DOAJ) | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 131 (99–161) | 262 | 3 | ≈$5,070 | — | 0.0 |
| Journal of Cheminformatics | 132 (103–171) | 188 | 25 | $2,390 | Open access (DOAJ) | 0.0 |
| APL Bioengineering | 132 (107–162) | 102 | 18 | $2,750 | Open access (DOAJ) | 2.66 |
| Theoretical and Applied Genetics | 133 (97–190) | 326 | 23 | ≈$5,190 | Hybrid | 0.0 |
| Journal of Neurochemistry | 133 (82–183) | 307 | — | ≈$5,330 | — | 0.0 |
| Molecular Medicine Reports | 133 (105–163) | 306 | 38 | — | Hybrid | 10.8 |
| Developmental Biology | 133 (84–206) | 226 | 2 | ≈$3,550 | Hybrid | 0.0 |
| Experimental and Therapeutic Medicine | 133 (102–168) | 219 | 35 | — | Open access | 5.55 |
| FEMS Microbiology Reviews | 133 (85–179) | 66 | — | ≈$3,371 | Open access (DOAJ) | 0.0 |
| BMC Genomics | 134 (95–198) | 1,282 | 22 | $3,190 | Open access (DOAJ) | 0.0 |
| Breast Cancer Research | 134 (89–180) | 246 | 22 | $4,190 | Open access (DOAJ) | 1.3 |
| Open Life Sciences | 134 (96–172) | 197 | 65 | ≈$2,423 | Open access (DOAJ) | 2.91 |
| Human Cell | 134 (83–189) | 160 | 15 | ≈$2,490 | — | 5.13 |
| Journal of Heredity | 134 (96–187) | 102 | — | ≈$3,560 | Hybrid | 0.0 |
| The International Journal of Biochemistry & Cell Biology | 134 (96–180) | 75 | 2 | ≈$3,840 | — | 2.05 |
| BioFactors | 134 (97–177) | 68 | — | ≈$4,150 | — | 2.45 |
| Human Genetics and Genomics Advances | 135 (103–173) | 130 | 4 | $2,640 | Open access (DOAJ) | 0.0 |
| Biotechnology Progress | 136 (94–182) | 99 | 21 | ≈$4,160 | — | 2.1 |
| Stem Cells | 136 (92–193) | 77 | — | ≈$4,477 | Hybrid | 0.0 |
| European Journal of Medical Genetics | 136 (91–238) | 70 | 2 | ≈$3,330 | Hybrid | 0.0 |
| Seminars in Cell and Developmental Biology | 136 (74–169) | 62 | 16 | ≈$4,670 | Hybrid | 0.0 |
| Insect Molecular Biology | 136 (97–182) | 61 | 21 | ≈$4,140 | — | 0.0 |
| Reproduction Fertility and Development | 136 (96–164) | 59 | — | — | — | 0.0 |
| Scientific Reports | 137 (94–201) | 47,228 | 17 | $2,850 | Open access (DOAJ) | 1.64 |
| Clinical Cancer Research | 137 (103–185) | 502 | — | — | Hybrid | 0.0 |
| BMC Bioinformatics | 137 (93–206) | 328 | 27 | $3,090 | Open access (DOAJ) | 0.0 |
| Journal of Plant Research | 137 (86–195) | 65 | 20 | ≈$3,890 | — | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 138 (105–196) | 413 | 4 | ≈$4,010 | Hybrid | 0.0 |
| Phytochemistry | 138 (112–166) | 272 | 1 | ≈$4,350 | — | 0.0 |
| Developmental Dynamics | 138 (92–192) | 78 | 26 | ≈$4,430 | — | 0.0 |
| The Plant Journal | 139 (99–194) | 640 | — | ≈$5,450 | Hybrid | 0.4 |
| Chemical Biology & Drug Design | 139 (85–223) | 191 | — | ≈$3,920 | — | 0.0 |
| Journal of Clinical Laboratory Analysis | 139 (98–204) | 161 | 16 | $3,280 | Open access (DOAJ) | 0.0 |
| New Biotechnology | 139 (102–218) | 102 | 4 | $3,180 | Open access (DOAJ) | 0.0 |
| Pigment Cell & Melanoma Research | 139 (67–191) | 60 | — | ≈$5,000 | Hybrid | 0.0 |
| Clinical Proteomics | 139 (80–175) | 52 | 34 | $2,690 | Open access (DOAJ) | 0.0 |
| Cell Death Discovery | 140 (107–192) | 616 | 17 | $2,790 | Open access (DOAJ) | 1.24 |
| Cancer Research Communications | 140 (102–182) | 192 | — | $2,550 | Open access (DOAJ) | 0.0 |
| Structure | 140 (95–206) | 189 | 25 | ≈$9,350 | Hybrid | 0.0 |
| Environmental Microbiology | 140 (101–175) | 188 | — | ≈$4,640 | — | 0.0 |
| Experimental and Molecular Pathology | 140 (105–184) | 54 | 7 | $3,190 | Open access (DOAJ) | 4.15 |
| Genomics | 141 (108–187) | 206 | 2 | $3,460 | Open access (DOAJ) | 0.85 |
| Metabolomics | 141 (89–203) | 164 | 27 | ≈$3,890 | Hybrid | 0.0 |
| BMC Ecology and Evolution | 141 (106–188) | 136 | 28 | $2,990 | Open access (DOAJ) | 1.41 |
| PROTEOMICS | 141 (93–183) | 135 | 19 | ≈$4,650 | — | 1.39 |
| Annals of Laboratory Medicine | 141 (123–171) | 85 | 31 | — | Open access | 0.0 |
| Journal of Biochemical and Molecular Toxicology | 142 (88–233) | 519 | — | ≈$4,020 | — | 1.78 |
| Journal of Biomedical Informatics | 142 (110–172) | 189 | 8 | ≈$3,410 | — | 0.0 |
| Journal of Ginseng Research | 142 (98–211) | 93 | 5 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| New Microbes and New Infections | 142 (87–222) | 84 | 2 | $2,830 | Open access (DOAJ) | 0.0 |
| Biotechnology Letters | 143 (98–203) | 127 | 15 | ≈$3,890 | — | 1.64 |
| Pharmacology & Therapeutics | 143 (116–184) | 91 | 4 | ≈$5,660 | Hybrid | 0.0 |
| Molecular Genetics and Genomics | 144 (99–214) | 121 | 26 | ≈$3,990 | — | 1.8 |
| Neurology Genetics | 144 (109–205) | 78 | 67 | $3,300 | Open access (DOAJ) | 0.0 |
| Animal Microbiome | 145 (109–190) | 134 | 27 | $2,290 | Open access (DOAJ) | 0.0 |
| Molecular Therapy | 146 (36–190) | 558 | 5 | ≈$4,500 | Hybrid | 3.26 |
| Cancer Gene Therapy | 146 (118–184) | 116 | 14 | ≈$4,990 | Hybrid | 11.08 |
| Scientific Data | 147 (106–214) | 864 | 17 | $2,690 | Open access (DOAJ) | 0.0 |
| Current Biology | 147 (94–208) | 536 | 27 | ≈$7,030 | Hybrid | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 147 (114–187) | 179 | 3 | ≈$3,930 | Hybrid | 0.0 |
| Molecular Reproduction and Development | 147 (110–209) | 60 | — | ≈$4,260 | — | 0.0 |
| Evolution Letters | 147 (114–198) | 54 | 35 | $2,575 | Open access (DOAJ) | 0.0 |
| Translational Oncology | 148 (99–204) | 375 | 8 | $3,880 | Open access (DOAJ) | 0.0 |
| Aging Cell | 148 (105–188) | 347 | 19 | $3,790 | Open access (DOAJ) | 0.0 |
| Biochemical Genetics | 148 (93–211) | 277 | 14 | ≈$4,090 | — | 1.64 |
| Current Medical Science | 148 (92–257) | 134 | 27 | ≈$3,890 | — | 0.0 |
| Journal of Molecular Evolution | 148 (117–242) | 58 | 19 | ≈$4,090 | — | 0.0 |
| Brazilian Journal of Microbiology | 149 (102–200) | 253 | 23 | ≈$3,190 | — | 0.0 |
| Cellular & Molecular Biology Letters | 149 (113–186) | 163 | 29 | $2,990 | Open access (DOAJ) | 0.0 |
| Journal of Extracellular Biology | 149 (123–190) | 66 | 36 | $3,340 | Open access (DOAJ) | 0.0 |
| Indian Journal of Medical Microbiology | 150 (108–211) | 152 | 2 | ≈$2,210 | Open access | 2.82 |
| Endocrine Related Cancer | 150 (95–202) | 114 | 15 | — | Hybrid | 0.0 |
| Human Genetics | 150 (92–204) | 86 | 24 | ≈$3,690 | — | 0.0 |
| Lipids | 150 (91–198) | 56 | 15 | ≈$3,589 | — | — |
| The American Journal of Human Genetics | 151 (110–211) | 191 | 25 | ≈$5,150 | — | 0.0 |
| Nucleic Acids Research | 152 (79–240) | 1,496 | — | $4,192 | Open access (DOAJ) | 0.32 |
| Molecular Biology and Evolution | 152 (114–206) | 329 | — | $3,255 | Open access (DOAJ) | 0.0 |
| The Journal of Pathology | 152 (106–214) | 119 | 45 | ≈$5,450 | Hybrid | 0.0 |
| Plant Communications | 153 (106–196) | 260 | 3 | $3,500 | Open access (DOAJ) | 0.0 |
| Molecular Oncology | 153 (103–216) | 193 | 19 | $4,730 | Open access (DOAJ) | 1.02 |
| International Journal of Antimicrobial Agents | 153 (110–192) | 188 | 6 | ≈$3,280 | Hybrid | 1.03 |
| Cell Biochemistry and Function | 153 (109–183) | 106 | — | ≈$4,220 | — | 0.0 |
| International Journal of Cancer | 154 (118–197) | 473 | 16 | ≈$5,030 | Hybrid | 0.0 |
| Open Medicine | 154 (107–213) | 197 | 57 | ≈$2,423 | Open access (DOAJ) | 8.51 |
| NAR Cancer | 154 (118–195) | 60 | 28 | $2,391 | Open access (DOAJ) | 0.0 |
| Journal of Cell Science | 155 (101–204) | 210 | 46 | — | Hybrid | 0.0 |
| npj Breast Cancer | 155 (107–223) | 169 | 23 | $3,890 | Open access (DOAJ) | 0.0 |
| npj Systems Biology and Applications | 155 (113–203) | 152 | 25 | $3,490 | Open access (DOAJ) | 0.0 |
| Access Microbiology | 155 (113–243) | 134 | 31 | ≈$1,344 | Open access (DOAJ) | 0.0 |
| Journal of Cellular Physiology | 155 (107–190) | 93 | — | ≈$5,230 | Hybrid | 0.91 |
| Patterns | 155 (121–191) | 85 | 27 | $4,900 | Open access (DOAJ) | 0.0 |
| Cancer Prevention Research | 155 (110–210) | 71 | — | — | Hybrid | 0.0 |
| Molecular Neurobiology | 156 (100–234) | 936 | 15 | ≈$4,590 | Hybrid | 0.31 |
| NAR Genomics and Bioinformatics | 156 (125–204) | 217 | 27 | $2,633 | Open access (DOAJ) | 1.26 |
| Molecular Phylogenetics and Evolution | 156 (114–226) | 149 | 3 | ≈$3,830 | Hybrid | 1.04 |
| European Journal of Paediatric Neurology | 156 (123–230) | 95 | 2 | ≈$2,940 | Hybrid | 0.0 |
| Blood Cancer Discovery | 156 (4–233) | 67 | — | — | Hybrid | 4.9 |
| PLoS ONE | 157 (106–229) | 16,959 | 34 | $2,477 | Open access (DOAJ) | 6.53 |
| Plant Molecular Biology | 158 (102–207) | 119 | 31 | ≈$4,590 | — | 0.0 |
| Plant Direct | 158 (100–225) | 89 | 26 | $3,120 | Open access (DOAJ) | 0.0 |
| Journal of The Royal Society Interface | 158 (134–186) | 71 | — | — | Hybrid | 0.0 |
| mLife | 158 (122–185) | 56 | 124 | $2,500 | Open access (DOAJ) | — |
| Molecular Therapy — Methods & Clinical Development | 159 (114–206) | 191 | 4 | $3,900 | Open access (DOAJ) | 0.0 |
| Cancer Discovery | 159 (20–234) | 174 | — | — | Hybrid | 0.0 |
| MicrobiologyOpen | 160 (112–235) | 178 | — | $3,720 | Open access (DOAJ) | 0.0 |
| Heredity | 160 (114–277) | 72 | 17 | ≈$2,690 | Hybrid | 0.0 |
| EBioMedicine | 161 (118–212) | 503 | 17 | $6,810 | Open access (DOAJ) | 0.0 |
| PLoS Genetics | 161 (118–217) | 373 | 21 | $3,165 | Open access (DOAJ) | 0.47 |
| Experimental & Molecular Medicine | 161 (113–211) | 233 | 85 | $4,690 | Open access (DOAJ) | 0.0 |
| Environmental Microbiology Reports | 161 (116–200) | 197 | — | ≈$3,300 | Hybrid | 0.0 |
| Physiology and Molecular Biology of Plants | 161 (113–222) | 162 | 23 | ≈$3,890 | — | 0.0 |
| International Journal of Microbiology | 161 (99–248) | 118 | 30 | $1,150 | Open access (DOAJ) | 0.0 |
| Journal of Cellular and Molecular Medicine | 162 (106–235) | 594 | — | $5,730 | Open access (DOAJ) | 1.66 |
| Bulletin of Mathematical Biology | 162 (114–202) | 174 | 25 | ≈$3,090 | Hybrid | 0.0 |
| Journal of Molecular Diagnostics | 162 (122–219) | 111 | 29 | ≈$3,000 | Hybrid | 0.0 |
| Cell Research | 162 (118–193) | 59 | 34 | ≈$5,190 | Hybrid | 0.0 |
| Journal of Molecular Cell Biology | 163 (106–219) | 62 | — | $2,730 | Open access (DOAJ) | 0.0 |
| npj Precision Oncology | 164 (118–219) | 461 | 21 | $4,290 | Open access (DOAJ) | 0.0 |
| Aging | 164 (109–267) | 140 | 21 | — | — | 2.44 |
| British Journal of Pharmacology | 165 (116–229) | 304 | 40 | ≈$4,780 | Hybrid | 0.73 |
| European Journal of Human Genetics | 165 (120–205) | 191 | 20 | ≈$2,790 | Hybrid | 0.0 |
| Molecular Therapy Oncology | 165 (117–193) | 116 | 3 | $3,900 | Open access (DOAJ) | 0.0 |
| Molecular Autism | 165 (118–210) | 61 | 24 | $3,990 | Open access (DOAJ) | 3.62 |
| Life Science Alliance | 166 (117–210) | 155 | 13 | $3,500 | Open access (DOAJ) | 0.0 |
| Journal of Physiology and Biochemistry | 166 (117–243) | 77 | 23 | ≈$4,490 | — | 0.0 |
| Bioinformatics | 168 (121–229) | 619 | — | $3,798 | Open access (DOAJ) | 0.51 |
| Cancer Cell International | 168 (113–243) | 503 | 19 | $3,290 | Open access (DOAJ) | 3.52 |
| Molecular Systems Biology | 168 (104–215) | 99 | 22 | $8,270 | Open access (DOAJ) | 0.0 |
| Stem Cells Translational Medicine | 168 (121–239) | 75 | — | $2,822 | Open access (DOAJ) | 0.0 |
| Evolution | 169 (104–263) | 258 | — | ≈$3,214 | Hybrid | 3.68 |
| Gene Therapy | 169 (134–251) | 71 | 14 | ≈$3,790 | — | 0.0 |
| Current Microbiology | 170 (119–239) | 644 | 16 | ≈$3,990 | Hybrid | 0.43 |
| npj Biofilms and Microbiomes | 171 (135–220) | 255 | 21 | $4,390 | Open access (DOAJ) | 0.0 |
| Molecular Therapy — Nucleic Acids | 171 (130–223) | 231 | 4 | $3,900 | Open access (DOAJ) | 8.36 |
| Radiation Research | 171 (104–308) | 111 | — | — | Hybrid | 0.0 |
| Database | 171 (129–216) | 80 | — | $2,598 | Open access (DOAJ) | 0.0 |
| EMBO Molecular Medicine | 172 (128–237) | 175 | 22 | $8,270 | Open access (DOAJ) | 1.39 |
| Genetics in Medicine | 172 (134–219) | 165 | 8 | ≈$5,110 | Hybrid | 0.0 |
| Development | 173 (125–224) | 244 | 39 | — | Hybrid | 0.0 |
| Journal of Theoretical Biology | 173 (130–250) | 178 | 8 | ≈$2,550 | — | 0.0 |
| Beneficial Microbes | 173 (120–257) | 52 | 21 | — | Hybrid | 0.0 |
| Advanced Pharmaceutical Bulletin | 174 (124–240) | 80 | 8 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Molecular & Cellular Proteomics | 175 (125–238) | 212 | 3 | $4,020 | Open access (DOAJ) | 0.0 |
| Molecular Genetics & Genomic Medicine | 175 (121–238) | 130 | — | $3,040 | Open access (DOAJ) | 2.03 |
| npj Imaging | 176 (117–217) | 56 | 40 | $2,890 | Open access (DOAJ) | — |
| Signal Transduction and Targeted Therapy | 177 (124–228) | 402 | 35 | $4,170 | Open access (DOAJ) | 0.0 |
| GigaScience | 177 (131–221) | 152 | — | $2,638 | Open access (DOAJ) | 0.0 |
| Cell Discovery | 177 (141–215) | 67 | 50 | $3,690 | Open access (DOAJ) | 0.0 |
| Molecular Ecology | 178 (123–246) | 396 | 14 | ≈$5,150 | Hybrid | 0.49 |
| Journal of Applied Genetics | 178 (110–241) | 104 | 19 | ≈$3,790 | Hybrid | 0.0 |
| Oncogenesis | 178 (130–213) | 51 | 21 | $4,390 | Open access (DOAJ) | 3.64 |
| Stem Cell Reports | 179 (118–230) | 182 | 29 | $4,400 | Open access (DOAJ) | 0.0 |
| Cell chemical biology | 179 (126–238) | 109 | 22 | ≈$9,350 | Hybrid | 0.0 |
| The Journal of General Physiology | 179 (103–293) | 53 | 27 | — | Hybrid | 0.0 |
| FEBS Journal | 180 (124–232) | 401 | 15 | ≈$5,000 | — | 0.0 |
| Phytotherapy Research | 181 (115–269) | 234 | 33 | ≈$4,880 | — | 0.0 |
| Biotechnology and Applied Biochemistry | 181 (110–234) | 193 | 21 | ≈$3,470 | Hybrid | 5.19 |
| Revista Argentina de Microbiología | 181 (129–253) | 51 | 41 | $1,200 | Open access (DOAJ) | 0.0 |
| iScience | 182 (133–254) | 2,505 | 4 | $3,240 | Open access (DOAJ) | 0.26 |
| Orphanet Journal of Rare Diseases | 182 (121–281) | 616 | 28 | $3,090 | Open access (DOAJ) | 0.43 |
| Oncogene | 182 (146–226) | 315 | 14 | ≈$5,990 | Hybrid | 2.31 |
| Journal of Neuroscience Research | 182 (132–263) | 84 | — | ≈$4,840 | — | 0.0 |
| Journal of Neurodevelopmental Disorders | 182 (124–267) | 80 | 38 | $3,090 | Open access (DOAJ) | 0.0 |
| British Journal of Cancer | 184 (146–236) | 344 | 23 | ≈$5,190 | Hybrid | 0.0 |
| EMBO Reports | 184 (112–248) | 289 | 21 | $8,270 | Open access (DOAJ) | 0.66 |
| Journal of Animal Breeding and Genetics | 184 (133–232) | 64 | 14 | ≈$4,750 | Hybrid | 0.0 |
| BMC Biology | 186 (136–271) | 374 | 18 | $3,790 | Open access (DOAJ) | 0.0 |
| npj Genomic Medicine | 186 (148–245) | 86 | 22 | $4,390 | Open access (DOAJ) | 0.0 |
| Interdisciplinary Sciences Computational Life Sciences | 187 (134–257) | 124 | 43 | ≈$3,990 | — | 0.0 |
| Microbiome | 188 (129–256) | 278 | 52 | $5,190 | Open access (DOAJ) | 0.0 |
| Archives of Pharmacal Research | 188 (130–264) | 61 | 12 | ≈$5,290 | — | 0.0 |
| Disease Models & Mechanisms | 189 (128–240) | 117 | 47 | $4,250 | Open access (DOAJ) | 0.0 |
| Journal of Extracellular Vesicles | 191 (144–243) | 170 | — | $4,850 | Open access (DOAJ) | 0.0 |
| Journal of Genetic Counseling | 191 (146–276) | 161 | — | ≈$3,840 | — | 0.0 |
| Molecular Ecology Resources | 191 (128–283) | 148 | 16 | ≈$5,250 | — | 2.39 |
| Medicinal Research Reviews | 192 (68–275) | 52 | 18 | ≈$4,980 | — | 0.0 |
| Cell Death and Disease | 193 (153–248) | 963 | 18 | $5,250 | Open access (DOAJ) | 2.14 |
| PLoS Biology | 194 (128–261) | 431 | 28 | $5,500 | Open access (DOAJ) | 1.01 |
| Journal of Evolutionary Biology | 194 (131–271) | 153 | — | ≈$3,123 | Hybrid | 1.44 |
| Molecular Cancer Research | 195 (145–249) | 71 | — | — | — | 0.0 |
| Molecular Horticulture | 195 (143–253) | 58 | 148 | $2,600 | Open access (DOAJ) | — |
| The EMBO Journal | 196 (134–251) | 319 | 27 | $8,270 | Open access (DOAJ) | 0.7 |
| Cell Genomics | 196 (145–278) | 177 | 28 | $8,900 | Open access (DOAJ) | 0.0 |
| Evolutionary Applications | 200 (155–266) | 118 | 23 | $4,320 | Open access (DOAJ) | 1.28 |
| PLoS Computational Biology | 201 (148–267) | 798 | 23 | $3,165 | Open access (DOAJ) | 0.0 |
| Cytometry Part A | 202 (126–247) | 59 | 15 | ≈$3,970 | Hybrid | 0.0 |
| Cell Reports | 204 (160–274) | 1,534 | 22 | $5,790 | Open access (DOAJ) | 0.0 |
| Cancer Cell | 206 (31–307) | 203 | 23 | ≈$10,400 | Hybrid | 0.0 |
| Bone Research | 208 (176–260) | 99 | 72 | $3,525 | Open access (DOAJ) | 2.98 |
| Molecular Cancer Therapeutics | 209 (157–271) | 174 | — | — | Hybrid | 0.0 |
| Cell Reports Methods | 210 (148–274) | 178 | 26 | $4,970 | Open access (DOAJ) | 0.0 |
| The Journal of Cell Biology | 212 (157–280) | 232 | 35 | — | Hybrid | 0.0 |
| Molecular Biomedicine | 212 (142–278) | 140 | 20 | $2,990 | Open access (DOAJ) | 0.0 |
| npj Regenerative Medicine | 214 (128–265) | 63 | 24 | $4,390 | Open access (DOAJ) | 0.0 |
| Genome Medicine | 215 (167–294) | 164 | 24 | $5,490 | Open access (DOAJ) | 0.0 |
| Communications Biology | 217 (165–292) | 1,969 | 16 | $4,390 | Open access (DOAJ) | 0.4 |
| Stem Cells International | 217 (147–320) | 96 | 34 | $2,830 | Open access (DOAJ) | 47.28 |
| Cell Metabolism | 223 (150–341) | 163 | 28 | ≈$10,400 | — | 0.0 |
| Molecular Cell | 224 (105–323) | 331 | 24 | ≈$10,400 | Hybrid | 0.62 |
| Cell Death and Differentiation | 225 (180–282) | 192 | 12 | ≈$5,790 | Hybrid | 0.0 |
| Archives animal breeding/Archiv für Tierzucht | 231 (161–341) | 55 | 69 | ≈$429 | Open access (DOAJ) | 0.0 |
| Nature Protocols | 232 (192–309) | 171 | 73 | — | — | 0.0 |
| Cancer Research | 233 (172–287) | 362 | — | — | Hybrid | 1.16 |
| Genome Research | 234 (181–309) | 207 | 62 | — | Hybrid | 0.0 |
| Journal of Mathematical Biology | 234 (174–315) | 153 | 25 | ≈$3,090 | Hybrid | 0.0 |
| eLife | 235 (133–409) | 87 | 15 | $3,750 | Open access (DOAJ) | 0.0 |
| BioMed Research International | 239 (155–320) | 205 | 35 | ≈$2,680 | — | 165.35 |
| Nature Communications | 242 (178–329) | 12,015 | 19 | $7,350 | Open access (DOAJ) | 0.27 |
| Nature Structural & Molecular Biology | 243 (187–357) | 163 | 40 | ≈$12,690 | Hybrid | 0.0 |
| Nature Computational Science | 244 (195–296) | 100 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Genetics Selection Evolution | 245 (193–325) | 81 | 22 | $2,470 | Open access (DOAJ) | 0.0 |
| Nature Plants | 246 (174–333) | 176 | 39 | ≈$12,690 | Hybrid | 0.0 |
| Journal of Clinical Investigation | 250 (176–369) | 479 | 8 | $5,700 | Open access (DOAJ) | 0.39 |
| MedComm | 256 (201–331) | 464 | 37 | $3,850 | Open access (DOAJ) | 0.0 |
| Cell stem cell | 266 (131–346) | 119 | 25 | ≈$10,400 | Hybrid | 0.0 |
| Nature Biotechnology | 275 (189–394) | 141 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Nature Metabolism | 276 (218–376) | 141 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Nature Microbiology | 279 (205–386) | 223 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Developmental Cell | 280 (102–385) | 205 | 24 | ≈$10,400 | Hybrid | 0.0 |
| Cell | 287 (185–399) | 478 | 27 | ≈$11,400 | Hybrid | 0.48 |
| Genome biology | 288 (211–384) | 434 | 18 | $5,690 | Open access (DOAJ) | 0.0 |
| Nature Aging | 309 (220–442) | 141 | 41 | ≈$12,690 | Hybrid | 1.27 |
| Cell Systems | 312 (221–410) | 138 | 27 | ≈$9,350 | Hybrid | 0.0 |
| Nature Cardiovascular Research | 316 (233–432) | 86 | 41 | ≈$12,690 | Hybrid | 0.0 |
| Nature Chemical Biology | 322 (233–396) | 173 | 39 | ≈$12,690 | Hybrid | 0.0 |
| Systematic Biology | 327 (211–468) | 82 | — | ≈$2,166 | Hybrid | 0.0 |
| Nature Cell Biology | 335 (245–416) | 151 | 47 | ≈$12,690 | Hybrid | 2.11 |
| Nature Cancer | 336 (253–467) | 109 | 43 | ≈$12,690 | Hybrid | 0.0 |
| Nature Methods | 338 (260–417) | 209 | 47 | ≈$12,690 | Hybrid | 0.68 |
| Genomics Proteomics & Bioinformatics | 350 (204–448) | 142 | — | $3,650 | Open access (DOAJ) | 0.0 |
| Nature Genetics | 390 (287–509) | 260 | 42 | ≈$12,690 | Hybrid | 0.0 |
| Nature Biomedical Engineering | 482 (384–588) | 202 | 48 | ≈$12,690 | — | 0.0 |
Journals are listed where at least 25% of their articles' topics fall in Biochemistry, Genetics and Molecular Biology (OpenAlex).
Latest available year: 2024
43 journals without enough usable 2025 data. Their 2024 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Biophysics Reports | 43 (27–74) | 59 | — | No fee (DOAJ) | Open access (DOAJ) | — |
| Biomolecular NMR Assignments | 50 (36–82) | 51 | 12 | ≈$3,890 | Hybrid | 0.0 |
| Biophysics and Physicobiology | 60 (37–92) | 55 | 2 | ≈$258 | Open access (DOAJ) | 0.0 |
| Current Opinion in Chemical Biology | 68 (46–103) | 92 | 23 | ≈$4,510 | Hybrid | 0.0 |
| Essays in Biochemistry | 71 (54–90) | 50 | — | — | — | 0.0 |
| Cell Stress and Chaperones | 72 (35–98) | 54 | 3 | $2,850 | Open access (DOAJ) | 10.53 |
| Plant Biotechnology | 76 (51–108) | 56 | — | — | Open access | 0.0 |
| Molecular and Cellular Probes | 78 (43–135) | 54 | 7 | $2,980 | Open access (DOAJ) | 0.0 |
| Medical Review | 78 (57–102) | 54 | 21 | No fee (DOAJ) | Open access (DOAJ) | — |
| Pathology & Oncology Research | 81 (52–120) | 66 | 15 | $2,500 | Open access (DOAJ) | 9.82 |
| Italian Journal of Food Safety | 83 (52–133) | 54 | 39 | ≈$462 | Open access (DOAJ) | 0.0 |
| Prostaglandins & Other Lipid Mediators | 83 (57–131) | 90 | 3 | ≈$3,500 | Hybrid | 0.0 |
| Archives of Medical Science | 87 (52–116) | 191 | 23 | ≈$2,308 | Open access (DOAJ) | 1.33 |
| Angiogenesis | 90 (68–141) | 51 | 21 | ≈$5,490 | Hybrid | 0.0 |
| Bioimpacts | 93 (66–140) | 67 | 76 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| International Journal of Clinical and Experimental Pathology | 94 (76–129) | 54 | 33 | — | — | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Bioenergetics | 94 (64–144) | 67 | 4 | ≈$4,680 | — | 0.0 |
| Molecular Syndromology | 97 (55–172) | 96 | 35 | — | — | 0.0 |
| Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics | 100 (80–132) | 152 | 156 | — | — | 0.0 |
| European Journal of Protistology | 101 (67–135) | 50 | 2 | ≈$3,270 | — | 0.0 |
| Chinese Journal of Natural Medicines | 103 (84–119) | 80 | — | ≈$3,000 | — | 0.0 |
| BJC Reports | 103 (72–151) | 76 | 36 | $2,790 | Open access (DOAJ) | — |
| Amino Acids | 106 (71–159) | 59 | 21 | $3,690 | Open access (DOAJ) | 0.0 |
| Journal of Cellular Biochemistry | 108 (78–149) | 99 | 16 | ≈$5,110 | — | 1.77 |
| Reports of Biochemistry and Molecular Biology | 108 (63–138) | 55 | — | ≈$150 | Open access | 0.0 |
| Transgenic Research | 112 (77–225) | 51 | 26 | ≈$3,990 | Hybrid | 0.0 |
| Journal of Crohn s and Colitis | 116 (88–150) | 108 | — | ≈$4,790 | — | 0.0 |
| European Journal of Cell Biology | 123 (97–165) | 75 | 3 | $3,010 | Open access (DOAJ) | 0.0 |
| Neoplasma | 125 (77–173) | 51 | — | — | — | 0.0 |
| The Journal of Infection in Developing Countries | 128 (93–196) | 230 | 227 | ≈$422 | Open access (DOAJ) | 0.0 |
| Molecular Informatics | 133 (92–152) | 51 | — | ≈$3,800 | — | 0.0 |
| npj Antimicrobials and Resistance | 141 (109–194) | 52 | 39 | $3,290 | Open access (DOAJ) | — |
| Indian Journal of Microbiology | 150 (93–230) | 253 | 20 | ≈$2,290 | — | 0.0 |
| Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology | 151 (103–222) | 72 | — | ≈$4,730 | — | 0.0 |
| Phenomics | 167 (124–223) | 57 | 197 | ≈$3,990 | — | — |
| Genes & Diseases | 171 (118–217) | 248 | 27 | $2,500 | Open access (DOAJ) | 0.0 |
| Genetics in Medicine Open | 171 (128–212) | 80 | 7 | $3,200 | Open access (DOAJ) | — |
| Chinese Herbal Medicines | 178 (125–250) | 56 | 4 | $1,200 | Open access (DOAJ) | 0.0 |
| Marine Life Science & Technology | 184 (146–236) | 58 | 54 | ≈$2,290 | — | 0.0 |
| Genetics and Molecular Biology | 191 (151–273) | 73 | 66 | $700 | Open access (DOAJ) | 0.0 |
| Bioinformatics and Biology Insights | 209 (129–256) | 81 | 46 | $2,650 | Open access (DOAJ) | 0.0 |
| Biochemistry and Molecular Biology Education | 290 (242–381) | 60 | 13 | ≈$3,700 | — | 0.0 |
| Theoretical Population Biology | 324 (246–369) | 51 | 5 | ≈$2,840 | Hybrid | — |
Latest available year: 2023
20 journals without enough usable 2025 data. Their 2023 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Polish Journal of Microbiology | 78 (65–91) | 51 | 77 | ≈$1,385 | Open access (DOAJ) | 0.0 |
| Genomics & Informatics | 83 (54–132) | 55 | 66 | $2,390 | Open access (DOAJ) | 0.0 |
| Journal of Molecular Recognition | 94 (57–129) | 57 | 18 | ≈$3,800 | — | 0.0 |
| Molecular and Cellular Neuroscience | 96 (72–132) | 64 | 5 | ≈$3,450 | — | 0.0 |
| Future Science OA | 97 (61–157) | 76 | 18 | ≈$1,942 | Open access (DOAJ) | 0.0 |
| Pharmacogenomics and Personalized Medicine | 98 (76–121) | 94 | 18 | $3,565 | Open access (DOAJ) | 2.54 |
| Biological Chemistry | 100 (71–130) | 76 | 20 | — | Hybrid | 0.0 |
| Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms | 104 (78–147) | 67 | 6 | ≈$3,840 | — | 0.0 |
| Current Molecular Pharmacology | 106 (75–154) | 62 | — | — | — | 0.0 |
| Research in Microbiology | 106 (79–151) | 86 | 7 | ≈$3,510 | Hybrid | 0.0 |
| Development Growth & Differentiation | 111 (59–173) | 54 | 23 | ≈$3,990 | — | 0.0 |
| Briefings in Functional Genomics | 111 (87–137) | 53 | — | ≈$3,700 | — | 0.0 |
| Yeast | 117 (77–164) | 50 | 17 | ≈$3,980 | Hybrid | — |
| Acta Biochimica Polonica | 125 (74–202) | 96 | — | $1,750 | Open access (DOAJ) | 2.57 |
| JBIC Journal of Biological Inorganic Chemistry | 126 (101–160) | 55 | 40 | ≈$3,990 | — | 0.0 |
| Oxidative Medicine and Cellular Longevity | 132 (95–176) | 75 | 22 | ≈$2,680 | — | 70.02 |
| Cell Biochemistry and Biophysics | 145 (81–229) | 53 | 15 | ≈$3,990 | — | 2.1 |
| Molecular Therapy — Oncolytics | 153 (128–188) | 52 | 3 | $3,900 | Open access (DOAJ) | 2.49 |
| Wilderness and Environmental Medicine | 154 (114–223) | 66 | 54 | ≈$4,150 | — | 0.0 |
| Forensic Sciences Research | 224 (161–368) | 63 | 60 | No fee (DOAJ) | Open access (DOAJ) | 11.95 |
Latest available year: 2022
23 journals without enough usable 2025 data. Their 2022 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Journal of Molecular Endocrinology | 15 (10–27) | 53 | 40 | — | Hybrid | — |
| Journal of Developmental Biology | 39 (31–53) | 51 | 5 | ≈$2,200 | Open access (DOAJ) | 0.0 |
| Molecular Cytogenetics | 43 (23–95) | 55 | 18 | $3,290 | Open access (DOAJ) | 0.0 |
| Computational and Mathematical Methods in Medicine | 43 (30–64) | 1,495 | 24 | ≈$2,550 | — | 489.53 |
| Frontiers in Fungal Biology | 52 (36–70) | 76 | 28 | ≈$2,383 | Open access (DOAJ) | 0.0 |
| Oncotarget | 55 (42–98) | 60 | 16 | — | Open access | 0.0 |
| Life Medicine | 58 (34–81) | 54 | 4 | No fee (DOAJ) | Open access (DOAJ) | — |
| Journal of Oncology | 59 (36–101) | 977 | 30 | ≈$2,550 | — | 20.7 |
| Frontiers in Genome Editing | 60 (39–93) | 58 | 23 | ≈$3,117 | Open access (DOAJ) | 0.0 |
| Molecular Case Studies | 67 (51–100) | 53 | 56 | — | Open access | — |
| Disease Markers | 68 (42–115) | 803 | 23 | ≈$2,550 | — | 105.18 |
| The Journal of Membrane Biology | 71 (47–95) | 57 | 24 | ≈$3,890 | — | — |
| European Journal of Histochemistry | 72 (47–111) | 52 | 20 | ≈$1,385 | Open access (DOAJ) | 0.0 |
| Emerging Topics in Life Sciences | 80 (55–100) | 57 | — | — | — | — |
| Genetics Research | 85 (54–123) | 83 | 27 | $2,100 | Open access (DOAJ) | — |
| American Journal of Medical Genetics Part C Seminars in Medical Genetics | 90 (49–121) | 54 | 17 | ≈$3,460 | — | 0.0 |
| Wiley Interdisciplinary Reviews - RNA | 95 (73–154) | 58 | 27 | ≈$4,780 | — | 0.0 |
| Glycoconjugate Journal | 97 (70–132) | 52 | 21 | ≈$2,590 | Hybrid | 4.61 |
| Methods and Applications in Fluorescence | 105 (75–135) | 66 | 12 | ≈$3,325 | — | — |
| Applied Biochemistry and Biotechnology | 119 (93–161) | 109 | 16 | ≈$3,890 | — | 3.13 |
| Analytical Cellular Pathology | 132 (89–171) | 71 | 25 | $2,380 | Open access (DOAJ) | 0.0 |
| BMC Molecular and Cell Biology | 141 (112–184) | 56 | 14 | $2,590 | Open access (DOAJ) | 0.0 |
| Progress in Biophysics and Molecular Biology | 146 (88–192) | 60 | 5 | ≈$4,260 | — | 0.0 |
Latest available year: 2021
24 journals without enough usable 2025 data. Their 2021 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Bosnian Journal of Basic Medical Sciences | 47 (33–77) | 76 | 223 | ≈$1,073 | Open access | — |
| Current Genetics | 63 (32–93) | 74 | 19 | ≈$4,390 | — | — |
| Applied and Environmental Microbiology | 64 (49–91) | 104 | 60 | No fee (DOAJ) | Open access (DOAJ) | 0.76 |
| The Breast Journal | 67 (22–106) | 122 | 19 | $2,580 | Open access (DOAJ) | 0.0 |
| Journal of Toxicologic Pathology | 77 (43–111) | 50 | — | — | Open access | — |
| Genes and Environment | 79 (58–112) | 58 | 20 | $2,590 | Open access (DOAJ) | — |
| Journal of Industrial Microbiology & Biotechnology | 82 (59–103) | 76 | — | $2,756 | Open access (DOAJ) | 0.0 |
| Current Research in Microbial Sciences | 84 (52–123) | 78 | 4 | $3,300 | Open access (DOAJ) | 0.0 |
| Pathogens and Disease | 91 (65–120) | 57 | — | ≈$3,297 | — | — |
| Antimicrobial Agents and Chemotherapy | 94 (61–129) | 101 | 63 | — | Open access | 0.0 |
| Biotechnology for Biofuels | 95 (66–139) | 218 | 13 | $2,990 | Open access (DOAJ) | 0.0 |
| Engineering in Life Sciences | 95 (73–131) | 72 | 23 | $3,630 | Open access (DOAJ) | 15.81 |
| Sexual Development | 102 (76–163) | 56 | 92 | — | — | — |
| Chemistry and Physics of Lipids | 103 (76–126) | 63 | 4 | ≈$3,870 | — | 0.0 |
| Ikushugaku zasshi | 111 (81–157) | 51 | 93 | — | Open access | 0.0 |
| Journal of Bioenergetics and Biomembranes | 114 (82–141) | 55 | 14 | ≈$3,790 | — | 0.0 |
| Cells and Development | 115 (85–176) | 59 | 8 | ≈$3,450 | — | 0.0 |
| Cellular Microbiology | 117 (65–184) | 69 | 25 | $2,580 | Open access (DOAJ) | — |
| Prostaglandins Leukotrienes and Essential Fatty Acids | 121 (84–160) | 60 | 5 | ≈$3,790 | Hybrid | 0.0 |
| Journal of the International Society of Sports Nutrition | 125 (91–209) | 62 | 18 | $2,630 | Open access (DOAJ) | 0.0 |
| Journal of Pediatric Genetics | 126 (87–183) | 64 | 51 | — | — | — |
| JCO Precision Oncology | 142 (99–199) | 108 | 40 | — | Hybrid | 0.89 |
| Science Advances | 156 (115–208) | 1,022 | 47 | $5,450 | Open access (DOAJ) | 0.17 |
| Molecular vision | 269 (192–397) | 62 | 2 | No fee (DOAJ) | Open access (DOAJ) | 4.85 |
Latest available year: 2020
19 journals without enough usable 2025 data. Their 2020 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Cellular and Molecular Biology | 20 (10–141) | 183 | 31 | — | — | 0.0 |
| Journal of Bacteriology | 62 (40–110) | 191 | 62 | No fee (DOAJ) | Open access (DOAJ) | 0.0 |
| Molecular and Cellular Biology | 85 (59–132) | 68 | 68 | — | — | 0.0 |
| Journal of Biomolecular NMR | 86 (73–105) | 52 | 14 | ≈$3,790 | — | — |
| Extremophiles | 93 (59–137) | 59 | 15 | ≈$2,590 | — | — |
| Current Genomics | 94 (71–128) | 66 | — | — | — | — |
| International Journal of Sport Nutrition and Exercise Metabolism | 96 (74–129) | 59 | 64 | — | — | 8.55 |
| Journal of Breast Cancer | 96 (63–153) | 61 | — | $500 | Open access (DOAJ) | 0.0 |
| Environmental and Molecular Mutagenesis | 98 (63–132) | 54 | 21 | ≈$3,750 | — | 0.0 |
| Cytogenetic and Genome Research | 104 (81–150) | 56 | 86 | — | — | 0.0 |
| Cancer Biology and Medicine | 110 (89–130) | 74 | — | $2,800 | Open access (DOAJ) | 0.0 |
| Cellular and Molecular Bioengineering | 120 (90–187) | 54 | 12 | ≈$3,690 | — | 0.0 |
| Applications in Plant Sciences | 127 (101–169) | 55 | 90 | $2,460 | Open access (DOAJ) | — |
| Developmental Neurobiology | 140 (84–188) | 59 | 25 | ≈$4,550 | — | — |
| Acta Biochimica et Biophysica Sinica | 142 (83–179) | 60 | — | ≈$1,862 | Open access (DOAJ) | 0.95 |
| Genetic Epidemiology | 151 (118–197) | 70 | 21 | ≈$4,150 | — | — |
| BMC Genetics | 162 (102–260) | 124 | 13 | $2,290 | Open access (DOAJ) | — |
| BMC Medical Genetics | 162 (107–260) | 224 | 13 | $3,290 | Open access (DOAJ) | — |
| BMC Evolutionary Biology | 181 (132–264) | 145 | 15 | $2,990 | Open access (DOAJ) | — |
Have a deadline?
Pick up to five journals and see whether a submission sequence can realistically reach acceptance before your defence, visa or job-market date. Free.
Open the submission plannerFrequently asked questions
Which Biochemistry, Genetics and Molecular Biology journals accepted papers fastest in 2025?
Among 630 Biochemistry, Genetics and Molecular Biology journals with enough dated articles in 2025, the shortest median time from submission to acceptance was 0 days (Anti-Cancer Drugs). The middle journal's median was 113 days. Speed is not a measure of quality; check scope, indexing and fees too.
How are these times measured?
From the submission and acceptance dates publishers deposit in PubMed, for accepted articles only. Each journal needs at least 50 dated articles in the year shown, and a table headed with a year contains only that year's figures.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.